With South Korea increasingly focusing on nuclear energy, the management of spent nuclear fuel has attracted considerable attention in South Korea. This study established a novel procedure for selecting safety-relevant radionuclides for long-term safety assessments of a deep geological repository in South Korea. Statistical evaluations were performed to identify the design basis reference spent nuclear fuels and evaluate the source term for up to one million years. Safety-relevant radionuclides were determined based on the half-life criteria, the projected activities for the design basis reference spent nuclear fuel, and the annual limit of ingestion set by the Nuclear Safety and Security Commission Notification No. 2019-10 without considering their chemical and hydrogeological properties. The proposed process was used to select 56 radionuclides, comprising 27 fission and activation products and 29 actinide nuclides. This study explains first the determination of the design basis reference spent nuclear fuels, followed by a comprehensive discussion on the selection criteria and methodology for safety-relevant radionuclides.

Spent nuclear fuel management is a high-priority issue in South Korea, and addressing it is crucial for the country’s long-term energy sustainability. The KORAD (Korea Radioactive Waste Agency) is leading a comprehensive, long-term project to develop a safe and effective deep geological repository for spent nuclear fuel disposal. Within this framework, we have three primary objectives in this work. First, we conducted statistical analysis to assess the inventory of spent nuclear fuel in South Korea as of 2021. We also projected future generation rates of spent nuclear fuels to identify what we refer to as reference spent nuclear fuels. These reference spent nuclear fuels will be used as the design basis spent fuels for evaluating the safety of the repository. Specifically, we identified four types of design basis reference spent nuclear fuels: high and low burnup from PLUS7 (with a 16×16 array) and ACE7 (with a 17×17 array) assemblies. Second, we analyzed radioactive nuclides’ inventory, activities, and decay heats, extending up to a million years after reactor discharge for these reference spent nuclear fuels. This analysis was performed using SCALE/TRITON to generate the burnup libraries and SCALE/ORIGEN for source term evaluation. Third, to assess the safety resulted from potential radioactive nuclides’ release from the disposal canister in future work, we selected safety-related radionuclides based on the ALI (Annual Limit of Intake) specified in Annex 3 of the 2019-10 notification by the NSSC (Nuclear Safety and Security Commission). Conservative assumptions were made regarding annual water intake by humans, canister design lifetime, and aquifer flow rates. A safety margin of 10-3 of the ALI was applied. We selected 56 radionuclides that exceed the intake limits and have half-lives longer than one year as the safety-related radionuclides. However, it is crucial to note that our selection criteria focused on ALI and half-lives. It did not include other essential factors such as solubility limits, distribution coefficients, and leakage processes. So, some of these nuclides can be removed in a specific analysis area depending on their properties.

The objective of this study was to establish an in vitro culture system for ovarian preantral follicles of B6D2F1. First, we optimized the in vitro preantral-follicle culture by culture duration, follicle stimulating hormone (FSH) type, and activin A concentration. Duration of in vitro culture for 9, 11, and 13 days was sufficient for the normal development of preantral follicles to antral follicles. Formation of cumulus cell–oocyte complex (COC) was induced by treatment with human chorionic gonadotropin (hCG; 2.5 IU/mL) and epidermal growth factor (EGF; 5 ng/mL). In addition, metaphase II (MII) oocytes formed during this in vitro culture of preantral follicles. In vitro preantral-follicle culture for 9 days showed higher rates of growth and maturation, thus yielding a greater number of antral follicles, and there were significant differences (p < 0.05) in the number of MII oocytes (that formed from these preantral follicles via differentiation) between the 9-day culture and 11-day or 13-day culture. The follicles cultured for 9 days contained a tightly packed well-defined COC, whereas in follicles cultured for 11 days, the COC was not well defined (spreading was observed in the culture dish); the follicles cultured for 13 days disintegrated and released the oocyte. Second, we compared the growth of the preantral follicles in vitro in the presence of various FSH types. There were no significant differences in the growth and maturation rates and in differentiation into MII oocytes during in vitro culture between preantral follicles supplemented with FSH from Merck and those supplemented with FSH from Sigma. To increase the efficiency of MII oocyte formation, the preantral follicles were cultured at different activin A concentrations (0 to 200 ng/mL). The control follicles, which were not treated with activin A, showed the highest rate of differentiation into antral follicles and into MII oocytes among all the groups (0 to 200 ng/mL). Therefore, activin A (50 to 200 ng/mL) had a negative effect on oocyte maturation. Thus, in this study, we propose an in vitro system of preantral-follicle culture that can serve as a therapeutic strategy for fertility preservation of human oocytes for assisted reproductive medicine, for conservation of endangered species, and for creation of superior breeds.

Contemporary systems for in vitro culture of ovarian follicles do not recapitulate the mechanical heterogeneity in mammalian ovary. Here we report microfluidic generation of biomimetic ovarian microtissue for miniaturized three-dimensional (3D) culture of early secondary preantral follicles by using alginate (harder) and collagen (softer) to fabricate the ovarian cortical and medullary tissues, respectively. This biomimetic configuration greatly facilitates follicle development to antral stage. Moreover, it enables in vitro ovulation of cumulus-oocyte complex (COC) from the antral follicles in the absence of luteinizing hormone (LH) and epidermal growth factor (EGF) that are well accepted to be responsible for ovulation in contemporary literature. These data reveal the crucial role of mechanical heterogeneity in the mammalian ovary in regulating follicle development and ovulation. The biomimetic ovarian microtissue and the microfluidic technology developed in this study are valuable for improving in vitro culture of follicles to preserve fertility and for understanding the mechanism of follicle development and ovulation to facilitate the search of cures to infertility due to ovarian disorders.